1. Home
  2. INMB vs MCHX Comparison

INMB vs MCHX Comparison

Compare INMB & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$2.03

Market Cap

64.7M

Sector

Health Care

ML Signal

HOLD

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

N/A

Current Price

$1.31

Market Cap

67.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
INMB
MCHX
Founded
2015
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
64.7M
67.3M
IPO Year
2018
2003

Fundamental Metrics

Financial Performance
Metric
INMB
MCHX
Price
$2.03
$1.31
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $5.40
N/A
AVG Volume (30 Days)
★ 315.2K
40.3K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 11.85
N/A
EPS
N/A
★ N/A
Revenue
$50,000.00
★ $90,291,000.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 257.14
N/A
52 Week Low
$1.09
$1.15
52 Week High
$2.60
$2.04

Technical Indicators

Market Signals
Indicator
INMB
MCHX
Relative Strength Index (RSI) 43.69 35.39
Support Level $1.97 $1.15
Resistance Level $2.17 $1.73
Average True Range (ATR) 0.16 0.15
MACD -0.05 -0.01
Stochastic Oscillator 15.15 24.62

Price Performance

Historical Comparison
INMB
MCHX

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

Share on Social Networks: